AVGO
63
-3
CVX
28
2
EMN
46
-2
ECL
50
3
TRV
49
-3
EQR
31
-2
PEP
39
12
KMI
61
4
BWA
50
-2
ZBH
53
3
UAL
45
-3
DE
46
-3
AZO
63
-2
XYL
56
-6
DLTR
51
-4
HBI
49
-15
VMC
60
-5
SE
88
5
MCHP
43
-12
ACN
47
-5
AVGO
63
-3
CVX
28
2
EMN
46
-2
ECL
50
3
TRV
49
-3
EQR
31
-2
PEP
39
12
KMI
61
4
BWA
50
-2
ZBH
53
3
UAL
45
-3
DE
46
-3
AZO
63
-2
XYL
56
-6
DLTR
51
-4
HBI
49
-15
VMC
60
-5
SE
88
5
MCHP
43
-12
ACN
47
-5
Financhill
Back

Apellis Pharmaceuticals Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.45
Seasonality Move:
2.29%
Sell
20

EYPT
EyePoint Pharmaceuticals

Last Price:
$5.68
Seasonality Move:
-0.86%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.44. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $5.68. The Score for EYPT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $5.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.67 Sell
Relative Strength Index (14 RSI): 42.89 Sell
Chaikin Money Flow: 20534 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.01 - 18.99) Sell
Bollinger Bands (100): (19.23 - 29.65) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 44.33 Sell
Chaikin Money Flow: 308638 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.77 - 6.73) Sell
Bollinger Bands (100): (5.54 - 7.6) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.42 Buy
20-day SMA: 18.11 Sell
50-day SMA: 19.97 Sell
200-day SMA: 28.53 Sell
8-day EMA: 17.62 Sell
20-day EMA: 18.04 Sell
50-day EMA: 20.09 Sell
200-day EMA: 28.66 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.85 Sell
20-day SMA: 6.22 Sell
50-day SMA: 5.92 Sell
200-day SMA: 7.8 Sell
8-day EMA: 5.87 Sell
20-day EMA: 6 Sell
50-day EMA: 6.14 Sell
200-day EMA: 7.99 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.09 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):